From Mendel to Medical Genetics: Milan Macek Jr. to Share Rare Disease Insights at ECTH 2025
European Congress on Thrombosis and Haemostasis (ECTH) posted on LinkedIn:
”From the legacy of Mendel to the frontlines of rare disease advocacy, Professor Milan Macek Jr., MD, DSc, is a true pioneer in medical genetics. As chair of the Czech Republic’s largest academic genetics centre and head of the National Coordination Centre for Rare Diseases, he’s shaping not just science, but national health strategies.
At ECTH 2025, Professor Milan Macek Jr. will take us on a journey through his session “From Mendel to medical genetics”, exploring how genetic breakthroughs are transforming diagnostics, care, and policy for rare diseases.
Expect a session that’s as visionary as it is practical; bridging history, cutting-edge research, and the real-world impact of coordinated action.
Join us at ECTH 2025.”
Stay updated with Hemostasis Today.
-
Jul 9, 2026, 13:16Olivier Mathieu: Innovating the Future of Hemostasis at ISTH 2026
-
Jul 9, 2026, 12:41Thomas Palmer-Dench: Hexokinase Controls Platelet Activation and Hemostasis
-
Jul 9, 2026, 12:19Paschalis Evangelidis: Join Our Special Issue on Thrombosis and Vascular Disorders
-
Jul 9, 2026, 12:16Fernanda Betti Solano: Could Iron Deficiency Be Affecting Your Sleep?
-
Jul 9, 2026, 12:08Andreas Calatzis: What is the Rationale for Collagen-Induced Platelet Aggregation Testing?
-
Jul 9, 2026, 11:54Deepak Pradhan։ Can Withaferin-A Help Combat Drug-Resistant Malaria?
-
Jul 9, 2026, 11:26Peter Zhang: Is Canada Ready for the Gene Therapy Era?
-
Jul 9, 2026, 09:35Pradeebha Muthukumar: Do You Know the Signs of Anemia?
-
Jul 9, 2026, 09:24Maryam Majid: Machine Learning for Anemia Risk Prediction